Stuart Johnson
  • Professor
  • Infectious Disease
Clostridium Difficile Infection, General Infectious Disease, Infection Complications in Surgery, Travel-Related Infection, Tuberculosis (TB)
Board Certifications
  • Infectious Disease - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine

Treatment of Clostridium Difficile InfectionsSoriano,M. M.; Johnson,S.INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 2015 ; ( ):

Clostridium difficile Infection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic SettingScardina,T.; Labuszewski,L.; Pacheco,S. M.; Adams,W.; Schreckenberger,P.; Johnson,S.INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 2015 ;36(3):280-286

Community-Associated Clostridium difficile Infection among Veterans with Spinal Cord Injury and DisorderBalbale,S. N.; Johnson,S.; Burns,S. P.; Kralovic,S. M.; Goldstein,B.; Gerding,D. N.; Evans,C. T.Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2014 ;35(5):577-580

Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorderRamanathan,S.; Johnson,S.; Burns,S. P.; Kralovic,S. M.; Goldstein,B.; Smith,B.; Gerding,D. N.; Evans,C. T.American Journal of Infection Control 2014 ;42(2):168-173

Changing Epidemiology of C. difficile and Emergence of New Virulent StrainsJohnson,S.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 ; ( ):

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard TherapiesSoriano,M. M.; Danziger,L. H.; Gerding,D. N.; Johnson,S.Open forum infectious diseases 2014 ;1(2):ofu069

Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralinBonchak,J. G.; Eby,J. M.; Willenborg,K. A.; Chrobak,D.; Henning,S. W.; Krzywiec,A.; Johnson,S. L.; Le Poole,I. C.ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 2014 ; ( ):

Enteric infectionsWang,M.; Johnson,S.Cancer treatment and research 2014 ;161( ):237-251

International typing study of Clostridium difficileManzo,C. E.; Merrigan,M. M.; Johnson,S.; Gerding,D. N.; Riley,T. V.; Silva,J.,Jr; Brazier,J. S.; the International Clostridium difficile Study GroupAnaerobe 2014 ; ( ):

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results from Two Multinational, Randomized, Controlled TrialsJohnson,S.; Louie,T. J.; Gerding,D. N.; Cornely,O. A.; Chasan-Taber,S.; Fitts,D.; Gelone,S. P.; Broom,C.; Davidson,D. M.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 ; ( ):

Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancyWang,M. S.; Evans,C. T.; Rodriguez,T.; Gerding,D. N.; Johnson,S.Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2013 ;34(2):127-132

Editorial Commentary: Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome?Gerding,D. N.; Johnson,S.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013 ;56(11):1601-1603

binary toxin CDT: Mechanism, epidemiology, and potential clinical importanceGerding,D. N.; Johnson,S.; Rupnik,M.; Aktories,K.Gut microbes 2013 ;5(1):

Important clinical advances in the understanding of Clostridium difficile infectionPacheco,S. M.; Johnson,S.CURRENT OPINION IN GASTROENTEROLOGY 2013 ;29(1):42-48

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.Figueroa,I.; Johnson,S.; Sambol,S. P.; Goldstein,E. J.; Citron,D. M.; Gerding,D. N.Clinical Infectious Diseases 2012 ;55(Suppl 2):S104-9

Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.Petrella,L. A.; Sambol,S. P.; Cheknis,A.; Nagaro,K.; Kean,Y.; Sears,P. S.; Babakhani,F.; Johnson,S.; Gerding,D. N.Clinical Infectious Diseases 2012 ;55(3):351-357

Meeting the challenge of recurrent Clostridium difficile infectionJohnson,S.Journal of Hospital Medicine (Online) 2012 ;7(Suppl 3):S11-3

Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.Siddiqui,F.; O'Connor,J. R.; Nagaro,K.; Cheknis,A.; Sambol,S. P.; Vedantam,G.; Gerding,D. N.; Johnson,S.Journal of Infectious Diseases 2012 ;205(1):128-133

Clostridium difficile infection in 2010: advances in pathogenesis, diagnosis and management of CDIGerding,Dale, N.; Johnson,StuartNature Reviews Gastroenterology & Hepatology 2011 ;8(2):67-68

Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolatesVenugopal,A. A.; Gerding,D. N.; Johnson,S.American Journal of Infection Control 2011 ;39(3):206-211

Management of Clostridium difficile infection: thinking inside and outside the boxGerding,D. N.; Johnson,S.Clinical Infectious Diseases 2010 ;51(11):1306-1313

Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands.Jabbar,U.; Leischner,J.; Kasper,D.; Gerber,R.; Sambol,S. P.; Parada,J. P.; Johnson,S.; Gerding,D. N.Infection Control & Hospital Epidemiology 2010 ;31(6):565-570

Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.Merrigan,M.; Venugopal,A.; Mallozzi,M.; Roxas,B.; Viswanathan,V. K.; Johnson,S.; Gerding,D. N.; Vedantam,G.Journal of Bacteriology 2010 ;192(19):4904-4911

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.Cheknis,A. K.; Sambol,S. P.; Davidson,D. M.; Nagaro,K. J.; Mancini,M. C.; Hidalgo-Arroyo,G. A.; Brazier,J. S.; Johnson,S.; Gerding,D. N.Anaerobe 2009 ;15(6):230-233

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomesJohnson,S.Journal of Infection 2009 ;58(6):403-410

Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.Johnson,S.; Schriever,C.; Patel,U.; Patel,T.; Hecht,D. W.; Gerding,D. N.Anaerobe 2009 ;15(6):290-291

Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat.Andrews,E. M.; Tsai,S. Y.; Johnson,S. C.; Farrer,J. R.; Wagner,J. P.; Kopen,G. C.; Kartje,G. L.Experimental neurology 2008 ;211(2):588-592

Misestimation of peer tobacco use: understanding disparities in tobacco useEdwards,C. L.; Bennett,G. G.; Wolin,K. Y.; Johnson,S.; Fowler,S.; Whitfield,K. E.; Askew,S.; MacKinnon,D.; McDougald,C.; Hubbard,R.; Wellington,C.; Feliu,M.; Robinson,E.Journal of the National Medical Association 2008 ;100(3):299-302

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.O'Connor,J. R.; Galang,M. A.; Sambol,S. P.; Hecht,D. W.; Vedantam,G.; Gerding,D. N.; Johnson,S.Antimicrobial Agents & Chemotherapy 2008 ;52(8):2813-2817

Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.Johnson,S.; Schriever,C.; Galang,M.; Kelly,C. P.; Gerding,D. N.Clinical Infectious Diseases 2007 ;44(6):846-848

Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital.Chang,H. T.; Krezolek,D.; Johnson,S.; Parada,J. P.; Evans,C. T.; Gerding,D. N.Infection Control & Hospital Epidemiology 2007 ;28(8):926-931

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.Hecht,D. W.; Galang,M. A.; Sambol,S. P.; Osmolski,J. R.; Johnson,S.; Gerding,D. N.Antimicrobial Agents & Chemotherapy 2007 ;51(8):2716-2719

Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.[see comment]Belmares,J.; Gerding,D. N.; Parada,J. P.; Miskevics,S.; Weaver,F.; Johnson,S.Journal of Infection 2007 ;55(6):495-501

Association of MC3R with body mass index in African Americans.Matsuoka,N.; Patki,A.; Tiwari,H. K.; Luke,A.; Wu,X.; Johnson,S. B.; Gregersen,P. K.; Allison,D. B.; Leibel,R. L.; Chung,W. K.International journal of body composition research 2007 ;5( ):123-130

Infection of hamsters with historical and epidemic BI types of Clostridium difficile.Razaq,N.; Sambol,S.; Nagaro,K.; Zukowski,W.; Cheknis,A.; Johnson,S.; Gerding,D. N.Journal of Infectious Diseases 2007 ;196(12):1813-1819

Tuberculous tenosynovitis.Aboudola,S.; Sienko,A.; Carey,R. B.; Johnson,S.Human pathology 2004 ;35(8):1044-1046

Meeting the challenge of recurrent Clostridium difficile infectionJohnson,S. ; ( ):

Medical School
  • University of Minnesota Medical School
  • University of Minnesota Hospital and Clinics, Internal Medicine: General
  • University of Minnesota Hospital and Clinics/VA Medical Center, Minneapolis, Infectious Diseases
  • Thai
  • Foreign movies
  • Travel
  • Hiking